vs

Side-by-side financial comparison of Cytek Biosciences, Inc. (CTKB) and UMH PROPERTIES, INC. (UMH). Click either name above to swap in a different company.

UMH PROPERTIES, INC. is the larger business by last-quarter revenue ($67.0M vs $62.1M, roughly 1.1× Cytek Biosciences, Inc.). UMH PROPERTIES, INC. runs the higher net margin — 6.8% vs -70.9%, a 77.8% gap on every dollar of revenue. On growth, UMH PROPERTIES, INC. posted the faster year-over-year revenue change (8.2% vs 8.1%). Over the past eight quarters, Cytek Biosciences, Inc.'s revenue compounded faster (17.7% CAGR vs 7.8%).

Cytek Biosciences, Inc. develops, manufactures and sells high-performance flow cytometry systems, associated reagents and analysis software. Its solutions serve life science research, clinical diagnostics and biopharmaceutical sectors, with a global customer base across North America, Europe and the Asia-Pacific region.

UMH Properties, Inc. is a public equity real estate investment trust (REIT) that owns and operates a portfolio of 135 manufactured home communities with approximately 25,700 developed homesites. These communities are located in 12 states: New Jersey, New York, Ohio, Pennsylvania, Tennessee, Indiana, Michigan, Maryland, Alabama, South Carolina, Georgia, and Florida. UMH also owns and operates two communities in Florida through its joint venture with Nuveen Real Estate.

CTKB vs UMH — Head-to-Head

Bigger by revenue
UMH
UMH
1.1× larger
UMH
$67.0M
$62.1M
CTKB
Growing faster (revenue YoY)
UMH
UMH
+0.1% gap
UMH
8.2%
8.1%
CTKB
Higher net margin
UMH
UMH
77.8% more per $
UMH
6.8%
-70.9%
CTKB
Faster 2-yr revenue CAGR
CTKB
CTKB
Annualised
CTKB
17.7%
7.8%
UMH

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CTKB
CTKB
UMH
UMH
Revenue
$62.1M
$67.0M
Net Profit
$-44.1M
$4.6M
Gross Margin
52.9%
Operating Margin
-9.0%
Net Margin
-70.9%
6.8%
Revenue YoY
8.1%
8.2%
Net Profit YoY
-557.1%
-8.1%
EPS (diluted)
$-0.01

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CTKB
CTKB
UMH
UMH
Q4 25
$62.1M
$67.0M
Q3 25
$52.3M
$66.9M
Q2 25
$45.6M
$66.6M
Q1 25
$41.5M
$61.2M
Q4 24
$57.5M
$61.9M
Q3 24
$51.5M
$60.7M
Q2 24
$46.6M
$60.3M
Q1 24
$44.9M
$57.7M
Net Profit
CTKB
CTKB
UMH
UMH
Q4 25
$-44.1M
$4.6M
Q3 25
$-5.5M
$9.3M
Q2 25
$-5.6M
$7.6M
Q1 25
$-11.4M
$4.8M
Q4 24
$9.6M
$5.0M
Q3 24
$941.0K
$12.9M
Q2 24
$-10.4M
$5.2M
Q1 24
$-6.2M
$-1.6M
Gross Margin
CTKB
CTKB
UMH
UMH
Q4 25
52.9%
Q3 25
52.7%
Q2 25
52.3%
Q1 25
48.6%
Q4 24
58.5%
Q3 24
56.3%
Q2 24
54.6%
Q1 24
51.3%
Operating Margin
CTKB
CTKB
UMH
UMH
Q4 25
-9.0%
Q3 25
-17.6%
Q2 25
-23.3%
Q1 25
-36.1%
Q4 24
5.2%
Q3 24
-8.2%
Q2 24
-18.3%
Q1 24
-23.9%
Net Margin
CTKB
CTKB
UMH
UMH
Q4 25
-70.9%
6.8%
Q3 25
-10.5%
13.9%
Q2 25
-12.2%
11.4%
Q1 25
-27.5%
7.9%
Q4 24
16.8%
8.0%
Q3 24
1.8%
21.3%
Q2 24
-22.4%
8.6%
Q1 24
-13.8%
-2.8%
EPS (diluted)
CTKB
CTKB
UMH
UMH
Q4 25
$-0.01
Q3 25
$0.05
Q2 25
$0.03
Q1 25
$0.00
Q4 24
$0.00
Q3 24
$0.11
Q2 24
$0.01
Q1 24
$-0.09

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CTKB
CTKB
UMH
UMH
Cash + ST InvestmentsLiquidity on hand
$90.9M
$72.1M
Total DebtLower is stronger
Stockholders' EquityBook value
$341.7M
$905.5M
Total Assets
$461.5M
$1.7B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CTKB
CTKB
UMH
UMH
Q4 25
$90.9M
$72.1M
Q3 25
$93.3M
$34.1M
Q2 25
$75.5M
$79.2M
Q1 25
$95.3M
$35.2M
Q4 24
$98.7M
$99.7M
Q3 24
$162.3M
$66.7M
Q2 24
$177.9M
$39.5M
Q1 24
$168.8M
$39.9M
Stockholders' Equity
CTKB
CTKB
UMH
UMH
Q4 25
$341.7M
$905.5M
Q3 25
$378.6M
$924.7M
Q2 25
$377.6M
$932.0M
Q1 25
$379.6M
$912.4M
Q4 24
$395.7M
$914.0M
Q3 24
$385.5M
$856.5M
Q2 24
$389.1M
$742.0M
Q1 24
$392.6M
$715.1M
Total Assets
CTKB
CTKB
UMH
UMH
Q4 25
$461.5M
$1.7B
Q3 25
$494.9M
$1.6B
Q2 25
$493.3M
$1.6B
Q1 25
$482.6M
$1.5B
Q4 24
$499.5M
$1.6B
Q3 24
$491.2M
$1.5B
Q2 24
$483.7M
$1.4B
Q1 24
$492.1M
$1.4B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CTKB
CTKB
UMH
UMH
Operating Cash FlowLast quarter
$-771.0K
$82.0M
Free Cash FlowOCF − Capex
$-1.8M
FCF MarginFCF / Revenue
-2.9%
Capex IntensityCapex / Revenue
1.6%
Cash ConversionOCF / Net Profit
17.92×
TTM Free Cash FlowTrailing 4 quarters
$-8.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CTKB
CTKB
UMH
UMH
Q4 25
$-771.0K
$82.0M
Q3 25
$-3.9M
$23.4M
Q2 25
$108.0K
$24.4M
Q1 25
$-125.0K
$12.8M
Q4 24
$2.0M
$81.6M
Q3 24
$13.2M
$16.7M
Q2 24
$6.2M
$18.6M
Q1 24
$4.0M
$19.0M
Free Cash Flow
CTKB
CTKB
UMH
UMH
Q4 25
$-1.8M
Q3 25
$-4.6M
Q2 25
$-1.5M
Q1 25
$-974.0K
Q4 24
$1.1M
Q3 24
$12.2M
Q2 24
$5.2M
Q1 24
$3.4M
FCF Margin
CTKB
CTKB
UMH
UMH
Q4 25
-2.9%
Q3 25
-8.7%
Q2 25
-3.2%
Q1 25
-2.3%
Q4 24
1.9%
Q3 24
23.7%
Q2 24
11.0%
Q1 24
7.6%
Capex Intensity
CTKB
CTKB
UMH
UMH
Q4 25
1.6%
Q3 25
1.3%
Q2 25
3.5%
Q1 25
2.0%
Q4 24
1.6%
Q3 24
2.0%
Q2 24
2.3%
Q1 24
1.3%
Cash Conversion
CTKB
CTKB
UMH
UMH
Q4 25
17.92×
Q3 25
2.53×
Q2 25
3.21×
Q1 25
2.66×
Q4 24
0.21×
16.39×
Q3 24
14.05×
1.30×
Q2 24
3.58×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CTKB
CTKB

Products$46.6M75%
Services$15.5M25%

UMH
UMH

Segment breakdown not available.

Related Comparisons